USPTO grants patent to AIM ImmunoTech’s Ampligen for endometriosis treatment: Ocala, Florida Monday, October 7, 2024, 15:00 Hrs [IST] AIM ImmunoTech Inc. announced that the Unit ...

AIM Stock Performance and Moving Averages. In recent trading, AIM ImmunoTech Inc (AIM) stock price has shown some volatility, fluctuating -5.89% over the last five trades and -20.

佛罗里达州奥卡拉 - AIM ImmunoTech Inc.宣布对其高管薪酬结构进行调整，包括削减首席执行官Thomas K. Equels的现金薪酬，并修正Equels和另一位高管的雇佣协议。 周三，AIM ImmunoTech董事会薪酬委员会决定将Equels的短期现金薪酬从75万美元降至65万美元。10万美元的减少部分将以公司普通股的限制性股票进行补偿。这些股票的价值将按2024年9月10日 ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States Patent and Trademark Office (USPTO) has granted U.S. patent No. 12,102,649, covering both ...

OCALA, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today ...

The gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $1.26 million before deducting the placement agent’s fees and ...

OCALA, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement ...

OCALA, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States Patent and Trademark Office (USPTO ...

OCALA, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States ...

Register to read this story and more for free. Signing up for an account helps us improve your browsing experience.

Short interest in AIM ImmunoTech Inc (AMEX:AIM) decreased during the last reporting period, falling from 520.20K to 498.08K. This put 0.89% of the company's publicly available shares short.